(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) dropped 7.79% to $0.31 at 20:41 EST on Saturday, after four sequential sessions in a row of losses. NASDAQ is sliding 2.72% to $13,768.92, after four successive sessions in a row of losses. This seems, at the moment, an all-around down trend exchanging session today.
TherapeuticsMD’s last close was $0.31, 88.6% under its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 4109740 which is 33.17% below its average volume of 6149875.
TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.18%, a negative 0.94%, and a positive 5.78%, respectively.
TherapeuticsMD’s highest amplitude of average volatility was 3.53% (last week), 4.48% (last month), and 5.78% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be overbought (>=80).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.31 at 20:41 EST, way under its 52-week low of $0.37.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s value is way below its 50-day moving average of $0.66 and way under its 200-day moving average of $1.00.
More news about TherapeuticsMD (TXMD).